Clinical Trial Update: A Multicenter, Randomized, Double-blind, Placebo Controlled, Clinical Trial to Evaluate the Safety, Tolerability and Preliminary Effectiveness of 2 Doses of Intradiscal rhGDF-5 (Single Administration) for the Treatment of Early Stage Lumbar Disc Degeneration [Phase 2]

View source ↗

Summary

A Phase 2 multicenter randomized, double-blind, placebo-controlled trial evaluated the safety and preliminary effectiveness of two intradiscal doses of rhGDF-5 …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Degenerative Disc Disease

Drugs mentioned

• rhGDF-5 (recombinant human growth differentiation factor-5)

Snippet

Sponsor: DePuy Spine | Conditions: Degenerative Disc Disease | Phase 2 | Status: COMPLETED | Results posted: 2016-02-24